Preclinical evidence for anaplastic lymphoma kinase inhibitors as novel therapeutic treatments for cholangiocarcinoma

Preclinical evidence for anaplastic lymphoma kinase inhibitors as novel therapeutic treatments for cholangiocarcinoma

IntroductionBile duct cancer (cholangiocarcinoma, CCA) has a poor prognosis for patients, and despite recent advances in targeted therapies for other cancer types, it is still treated with standard chemotherapy. Anaplastic lymphoma kinase (ALK) has been shown to be a primary driver of disease progre...

Full description

Bibliographic Details
Main Authors:	Kyaw Zwar Myint, Mireia Sueca-Comes, Pamela Collier, Brinda Balasubramanian, Simran Venkatraman, John Gordan, Abed M. Zaitoun, Abhik Mukherjee, Arvind Arora, Noppadol Larbcharoensub, Chinnawut Suriyonplengsaeng, Kanokpan Wongprasert, Tavan Janvilisri, Dhanny Gomez, Anna M. Grabowska, Rutaiwan Tohtong, David O. Bates, Kiren Yacqub-Usman
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-12-01
Series:	Frontiers in Oncology
Subjects:	cholangiocarcinoma Opisthorchis viverrini anaplastic lymphoma kinase 1 novel therapeutics cytotoxicity and autophagy
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1184900/full

Similar Items

CP-673451, a Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces Apoptosis in <i>Opisthorchis viverrini</i>-Associated Cholangiocarcinoma via Nrf2 Suppression and Enhanced ROS
by: Jinchutha Duangdara, et al.
Published: (2023-12-01)

Programmed knockout mutation of liver fluke granulin attenuates virulence of infection-induced hepatobiliary morbidity
by: Patpicha Arunsan, et al.
Published: (2019-01-01)

Predictors of hookworm and Opisthorchis viverrini infection among adolescents in urban Laos: a cross-sectional study
by: Yoshida I, et al.
Published: (2019-05-01)

Targeting FGFRs Using PD173074 as a Novel Therapeutic Strategy in Cholangiocarcinoma
by: Brinda Balasubramanian, et al.
Published: (2023-04-01)

Risk Factors for Opisthorchis Viverrini Infection: A Systematic Review
by: Anuwat Pengput, et al.
Published: (2020-09-01)

Helminth infection-induced carcinogenesis: spectrometric insights from the liver flukes, Opisthorchis and Fasciola
by: Maria João Gouveia, et al.
Published: (2020-01-01)

Co-Clinical Trials: An Innovative Drug Development Platform for Cholangiocarcinoma
by: Brinda Balasubramanian, et al.
Published: (2021-01-01)

Repeated praziquantel treatment and Opisthorchis viverrini infection: a population-based cross-sectional study in northeast Thailand
by: Kavin Thinkhamrop, et al.
Published: (2019-03-01)

Prevalence of Opisthorchis viverrini and its Associated Risk Factors in the Phon Sawan District of Nakhon Phanom Province, Thailand
by: Chaiwat Srithai, et al.
Published: (2021-08-01)

Epidemiology of Opisthorchis viverrini in an endemic area of Thailand, an integrative approach
by: Prakobwong S., et al.
Published: (2017-12-01)

Endemicity of Opisthorchis viverrini Liver Flukes, Vietnam, 2011–2012
by: Jitra Waikagul, et al.
Published: (2014-01-01)

Effects of physicochemical factors on development and survival of Opisthorchis viverrini uterine eggs
by: Chanisala Sereewong, et al.
Published: (2018-01-01)

Association between cholangiocarcinoma and liver flukes: review of epidemiological studies
by: A. E. Kovshirina, et al.
Published: (2020-04-01)

Prevalence and Risk Factors of <em>Opisthorchis viverrini</em> Infection in Sakon Nakhon Province, Thailand
by: Pariyakorn Perakanya, et al.
Published: (2022-10-01)

Neutrophils form extracellular traps in response to Opisthorchis viverrini crude antigens, which are elevated in neutrophils from opisthorchiasis patients with hepatobiliary abnormalities
by: Krongkarn Watakulsin, et al.
Published: (2023-08-01)

Influence of geographic, knowledge and behavioral factors on Opisthorchis viverrini infection in the Northeast of Thailand
by: Kittipong Sornlorm, et al.
Published: (2019-01-01)

Mothers’ Opisthorchis viverrini infection status and raw fish dish consumption in Lao People’s Democratic Republic: determinants of child infection status
by: Hitomi Araki, et al.
Published: (2018-08-01)

The miRNAome of Opisthorchis viverrini induced intrahepatic cholangiocarcinoma
by: Jin Peng, et al.
Published: (2014-12-01)

Silencing of Opisthorchis viverrini Tetraspanin Gene Expression Results in Reduced Secretion of Extracellular Vesicles
by: Sujittra Chaiyadet, et al.
Published: (2022-02-01)

Current high prevalences of Strongyloides stercoralis and Opisthorchis viverrini infections in rural communities in northeast Thailand and associated risk factors
by: Pokkamol Laoraksawong, et al.
Published: (2018-07-01)

Fish and Food-Fatale: Food-borne Trematode Opisthorchis viverrini and Cholangiocarcinoma
by: Tan S., et al.
Published: (2023-12-01)

Monoclonal Antibodies Targeting an <i>Opisthorchis viverrini</i> Extracellular Vesicle Tetraspanin Protect Hamsters against Challenge Infection
by: Wuttipong Phumrattanaprapin, et al.
Published: (2021-07-01)

Seasonal cercarial emergence patterns of Opisthorchis viverrini infecting Bithynia siamensis goniomphalos from Vientiane Province, Lao PDR
by: Nadda Kiatsopit, et al.
Published: (2014-12-01)

Distinct antibody response in susceptible and non-susceptible hosts of the carcinogenic liver fluke Opisthorchis viverrini infection
by: Krongkarn Watakulsin, et al.
Published: (2023-07-01)

Perspectives in the vaccine development against Opisthorchis viverrini liver fluke
by: Ahmed O. Shalash, et al.
Published: (2022-09-01)

Adult Opisthorchis viverrini Flukes in Humans, Takeo, Cambodia
by: Woon-Mok Sohn, et al.
Published: (2011-07-01)

A systematic review of the effects of hepatitis B and C virus on the progression of liver fluke infection to liver cancer
by: Allison O’Rourke
Published: (2024-03-01)

Inflammatory cell responses in biliary mucosa during Opisthorchis viverrini infection: Insights into susceptibility differences among hosts
by: Theerayut Thongrin, et al.
Published: (2023-09-01)

Development of a PCR assay and pyrosequencing for identification of important human fish-borne trematodes and its potential use for detection in fecal specimens
by: Chairat Tantrawatpan, et al.
Published: (2014-03-01)

Low-Grade Endemicity of Opisthorchiasis, Yangon, Myanmar
by: Woon-Mok Sohn, et al.
Published: (2019-07-01)

In silico prediction of secretory proteins of Opisthorchis viverrini, Clonorchis sinensis and Fasciola hepatica that target the host cell nucleus
by: Claudia Machicado, et al.
Published: (2021-07-01)

Accuracy of a new rapid diagnostic test for urinary antigen detection and assessment of drug treatment in opisthorchiasis
by: Chanika Worasith, et al.
Published: (2023-11-01)

<i>Opisthorchis viverrini</i>—Current Understanding of the Neglected Hepatobiliary Parasite
by: Matthias Yi Quan Liau, et al.
Published: (2023-06-01)

Current Perspectives on Opisthorchiasis Control and Cholangiocarcinoma Detection in Southeast Asia
by: Narong Khuntikeo, et al.
Published: (2018-04-01)

Rapid assessment of Opisthorchis viverrini IgG antibody in serum: A potential diagnostic biomarker to predict risk of cholangiocarcinoma in regions endemic for opisthorchiasis
by: Rutchanee Rodpai, et al.
Published: (2022-03-01)

Association between helminth infections and diabetes mellitus in adults from the Lao People’s Democratic Republic: a cross-sectional study
by: Nan Shwe Nwe Htun, et al.
Published: (2018-11-01)

Structural Analysis of an Epitope Candidate of Triosephosphate Isomerase in Opisthorchis viverrini
by: Jonghyeon Son, et al.
Published: (2018-10-01)

RTK25: A Comprehensive Molecular Profiling Strategy in Cholangiocarcinoma Using an Integrated Bioinformatics Approach
by: Brinda Balasubramanian, et al.
Published: (2021-09-01)

WNT8B as an Independent Prognostic Marker for Nasopharyngeal Carcinoma
by: Chawalit Ngernsombat, et al.
Published: (2021-07-01)

Transcriptomic profiling revealed FZD10 as a novel biomarker for nasopharyngeal carcinoma recurrence
by: Warut Tulalamba, et al.
Published: (2023-01-01)